Results 211 to 220 of about 98,529 (269)

Bone Marker Proteins in Women With and Without Polycystic Ovary Syndrome. [PDF]

Int J Mol Sci
Atkin BML, Sathyapalan T, Dempsey L, Atkin SL, Butler AE.   +4 more
europepmc   +1 more source

Safety and efficacy of the therapy with CD4 + CD25highCD127‐T regulatory cells: When paediatric patient becomes adult

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1392-1402, February 2026.
Abstract Aim CD4 + CD25highCD127‐T regulatory cells (Tregs) remain a drug candidate for immunotherapy of type 1 diabetes. We completed three trials testing Tregs in recently diagnosed type 1 diabetes children. Here, we looked for long‐term safety and efficacy aspects important in the authorisation of this therapy.
Marta Bandura, Magdalena Piotrowska‐Mieczkowska, Matylda Hennig, Mateusz Gliwiński, Anna Wołoszyn‐Durkiewicz, Julia Schoenhoff, Milena Dybowska, Anna Alska, Piotr Gutknecht, Bartosz Trzeciak, Katarzyna Stefańska, Paulina Glasner, Marcin Hellmann, Jacek Burzyński, Arkadiusz Michalak, Janusz Siebert, Dorota Iwaszkiewicz‐Grześ, Małgorzata Myśliwiec, Piotr Trzonkowski   +18 more
wiley   +1 more source

Investigation of Isthmin-1 level in patients with polycystic ovary syndrome. [PDF]

BMC Womens Health
Özata B, Gürpinar AB, Şahin B.
europepmc   +1 more source

Unintentional periconceptional exposure to glucagon‐like peptide‐1 receptor agonists and adverse pregnancy outcomes: A nationwide cohort study in Taiwan

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1420-1430, February 2026.
Abstract Aims To assess whether periconceptional exposure to glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) is associated with adverse outcomes in women with pregestational type 2 diabetes. Materials and Methods We linked Taiwan's Birth Certificate Application and National Health Insurance claims (2013–2022) to assemble a nationwide cohort of ...
Yi‐Chang Chou, Shih‐Han Weng, Feng‐Shiang Cheng, Chih‐Hao Tseng, Hsiao‐Yun Hu, Chieh‐Hsing Liu   +5 more
wiley   +1 more source

Dickkopf1 as a Potential Biomarker in Polycystic Ovary Syndrome and Insulin Resistance: A Cross-Sectional Study. [PDF]

J Diabetes
Ling J, Wang H, Liu R, Xiao J, Qiu S, Lei X, Yang M, Lai Y, Huang H, Liang Z.   +9 more
europepmc   +1 more source

Adherence to Protocol Registration Among Systematic Reviews on Photobiomodulation: A Meta‐Research Study

Journal of Evaluation in Clinical Practice, Volume 32, Issue 1, February 2026.
ABSTRACT Aims and Objectives This meta‐research study mapped systematic reviews on photobiomodulation (PBM), encompassing low‐level laser therapy (LLLT) and light‐emitting diode (LED) modalities, to evaluate whether protocols were registered, whether published reviews adhered to and updated their PROSPERO records, and whether topic redundancy occurred ...
Giovanna Marcilio Santos, Giullia Carvalho Mangas Lopes, Kamilla Mayr Martins Sá, Giulia Almirón da Rocha Soares, Marcela Letícia Leal Gonçalves, Sandra Kalil Bussadori, Elaine Marcílio Santos, Ana Luiza Cabrera Martimbianco   +7 more
wiley   +1 more source

The Effects of <i>Chlorella vulgaris</i> on Polycystic Ovary Syndrome in Mice. [PDF]

Food Sci Nutr
Sun Y, Wang Y, Qi J, Gao R, Tan S, Wang S, Zhang Q, Gong X, Xing S, Sha Z.   +9 more
europepmc   +1 more source

Obacunone alleviated the development of polycystic ovary syndrome via inhibiting STAT3 phosphorylation. [PDF]

J Ovarian Res
Guan L, Wu H, Li Y, Yu Y, Xiang S, Lian F.   +5 more
europepmc   +1 more source

Biochemical and Physiological Effects of Galanin in Health and Disease

The FASEB Journal, Volume 40, Issue 2, 31 January 2026.
Galanin is a biologically active neuropeptide hormone that mediates its effects through three galanin receptors. Galanin signaling induces changes in glucose homeostasis amongst others and plays a dynamic role in the physiological health of many organ systems.
Patrick Mireles, Yubo Wang, Kathryn Rhodes, Sharon DeMorrow   +3 more
wiley   +1 more source